Quantifying the burden of disease and perceived health state in patients with Hereditary Angioedema in Japan: Patient-Reported Outcomes study
Not Applicable
- Conditions
- Hereditary Angioedema
- Registration Number
- JPRN-UMIN000042425
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Currently participating or planning to participate in any clinical trials and receiving any investigational agents for HAE treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the health-related quality of life of Japanese patients with HAE using AE-QO
- Secondary Outcome Measures
Name Time Method 1) To assess disease activity and mental health using AAS and HADS 2) To assess general health status and work productivity using SF-12 and WPAI